17 alpha-hydroxyprogesterone caproate has been researched along with Ischemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kiprono, LV; Lamarca, B; Martin, J; Moseley, J; Wallace, K | 1 |
| Bennett, W; Cockrell, K; Granger, JP; Keiser, SD; LaMarca, B; Martin, JN; Parrish, MR; Ray, LF; Veillon, EW | 1 |
2 other study(ies) available for 17 alpha-hydroxyprogesterone caproate and Ischemia
| Article | Year |
|---|---|
Progesterone blunts vascular endothelial cell secretion of endothelin-1 in response to placental ischemia.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Animals; Disease Models, Animal; Endothelial Cells; Endothelin-1; Enzyme-Linked Immunosorbent Assay; Female; Humans; Hydroxyprogesterones; Hypertension; Ischemia; Placenta; Placental Circulation; Pre-Eclampsia; Pregnancy; Progesterone; Progestins; Rats; Rats, Sprague-Dawley | 2013 |
17-Hydroxyprogesterone blunts the hypertensive response associated with reductions in uterine perfusion pressure in pregnant rats.
Topics: 17 alpha-Hydroxyprogesterone Caproate; 17-alpha-Hydroxyprogesterone; Animals; Endothelin-1; Female; Hydroxyprogesterones; Ischemia; Placenta; Placental Circulation; Pregnancy; Progesterone Congeners; Rats; Tumor Necrosis Factor-alpha | 2009 |